Triamcinolone Acetonide Extended Release Injectable Suspension + Ketoconazole Interaction
Moderateinteraction on record
Description
CYP 3A4 inhibitors (e.g., ketoconazole) Ketoconazole, a strong CYP3A4 inhibitor, has been reported to decrease the metabolism of certain corticosteroids by up to 60% leading to an increased risk of corticosteroid side effects.
Source: FDA drug label - triamcinolone acetonide extended-release injectable suspension